Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2015 | 1 |
2017 | 1 |
2018 | 1 |
2022 | 2 |
2023 | 1 |
Search Results
6 results
Results by year
Filters applied: . Clear all
Page 1
A Third Dose of the COVID-19 Vaccine, CVnCoV, Increased the Neutralizing Activity against the SARS-CoV-2 Wild-Type and Delta Variant.
Vaccines (Basel). 2022 Mar 25;10(4):508. doi: 10.3390/vaccines10040508.
Vaccines (Basel). 2022.
PMID: 35455257
Free PMC article.
Safety and immunogenicity of mRNA-LNP COVID-19 vaccine CVnCoV in Latin American adults: A phase 2 randomized study.
Sáez-Llorens X, Lanata C, Aranguren E, Celis CR, Cornejo R, DeAntonio R, Ecker L, Garrido D, Gil AI, Gonzales M, Hess-Holtz M, Leroux-Roels G, Junker H, Kays SK, Koch SD, Lazzaro S, Mann P, Quintini G, Srivastava B, Vahrenhorst D, von Eisenhart-Rothe P, Wolz OO, Oostvogels L.
Sáez-Llorens X, et al. Among authors: kays sk.
Vaccine X. 2022 Aug;11:100189. doi: 10.1016/j.jvacx.2022.100189. Epub 2022 Jul 1.
Vaccine X. 2022.
PMID: 35791320
Free PMC article.
Item in Clipboard
Neuraminidase-Inhibiting Antibody Titers Correlate with Protection from Heterologous Influenza Virus Strains of the Same Neuraminidase Subtype.
Walz L, Kays SK, Zimmer G, von Messling V.
Walz L, et al. Among authors: kays sk.
J Virol. 2018 Aug 16;92(17):e01006-18. doi: 10.1128/JVI.01006-18. Print 2018 Sep 1.
J Virol. 2018.
PMID: 29925654
Free PMC article.
Item in Clipboard
Corrigendum to "Safety and immunogenicity of mRNA-LNP COVID-19 vaccine CVnCoV in Latin American adults: A phase 2 randomized study" [Vaccine: X 11 (2022) 100189].
Sáez-Llorens X, Lanata C, Aranguren E, Celis CR, Cornejo R, DeAntonio R, Ecker L, Garrido D, Gil AI, Gonzales M, Hess-Holtz M, Leroux-Roels G, Junker H, Kays SK, Koch SD, Lazzaro S, Mann P, Quintini G, Srivastava B, Vahrenhorst D, von Eisenhart-Rothe P, Wolz OO, Oostvogels L.
Sáez-Llorens X, et al. Among authors: kays sk.
Vaccine X. 2023 Aug;14:100307. doi: 10.1016/j.jvacx.2023.100307. Epub 2023 Apr 28.
Vaccine X. 2023.
PMID: 37131960
Free PMC article.
Item in Clipboard
CD105 is a surface marker for receptor-targeted gene transfer into human long-term repopulating hematopoietic stem cells.
Kays SK, Kaufmann KB, Abel T, Brendel C, Bonig H, Grez M, Buchholz CJ, Kneissl S.
Kays SK, et al.
Stem Cells Dev. 2015 Mar 15;24(6):714-23. doi: 10.1089/scd.2014.0455. Epub 2015 Jan 20.
Stem Cells Dev. 2015.
PMID: 25517513
Free PMC article.
Item in Clipboard
Enhancing the Oncolytic Activity of CD133-Targeted Measles Virus: Receptor Extension or Chimerism with Vesicular Stomatitis Virus Are Most Effective.
Kleinlützum D, Hanauer JDS, Muik A, Hanschmann KM, Kays SK, Ayala-Breton C, Peng KW, Mühlebach MD, Abel T, Buchholz CJ.
Kleinlützum D, et al. Among authors: kays sk.
Front Oncol. 2017 Jun 26;7:127. doi: 10.3389/fonc.2017.00127. eCollection 2017.
Front Oncol. 2017.
PMID: 28695108
Free PMC article.
Item in Clipboard
Cite
Cite